Critical analysis on the use of the Homeostasis Hodel Assessment (HOMA) indexes in the evaluation of the insulin resistance and the pancreatic beta cells functional capacity;Análise crítica do uso dos índices do Homeostasis Model Assessment (HOMA) na avaliação da resistência à insulina e capacidade funcional das células-β pancreáticas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 1, 2008, Pages 32-39

  Vasques, Ana Carolina J ^a,c   Rosado, Lina Enriqueta F P L ^a   Alfenas, Rita De Cássia G ^a   Geloneze, Bruno ^b  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Campus da Universidade Federal de Viçosa   (Brazil)

Author keywords

Blood glucose; HOMA index; Insulin resistance; Insulinemia

Indexed keywords

EID: 41149104548     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000100006     Document Type: Review

References (56)

1. Matthews DR. Insulin resistance and β-cell function - a clinical perspective. Diabetes Obes Metab. 2001;3:28-33.
2. Porte DJR, Kahn SE. Cell dysfunction and failure in type 2 diabetes potential mechanisms. Diabetes. 2001;50:160-3.
3. Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets. 2007;7:65-74.
4. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007;375:20-35.
5. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001;86:3574-8.
6. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 2001;24:89-94.
7. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Insulin Resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indiana. Diabetes Care. 2003;26:861-7.
8. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;18:1888-904.
9. Bigazzi R, Bianchi S. Insulin resistance, metabolic syndrome and endothelial dysfunction. J Nephrol. 2007;20:10-4.
10. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The Atherosclerosis Risk in Communities Study. Diabetes. 2002;51:3069-76.
11. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25:1135-41.
12. Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res. 2007;61:345-9.
13. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care. 2002;25:1371-7.
14. Pereira LO, Francischi RP, Lancha Jr AH. Obesidade: hábitos nutricionais, sedentarismo e resistência à insulina. Arq Bras Endocrinol Metab. 2003;47:111-27.
15. Rojo-Martinez G, Esteva I, deAdana SR, Catala, M, Merelo MJ, Tinahones F, et al. Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract. 2004; 65:247-56.
16. Hermans MP, Pepersack TM, Godeaux LH, Beyer I, Turc AP. Prevalence and determinants of impaired glucose metabolism in frail elderly patients: The Belgian Elderly Diabetes Survey (BEDS). J Gerontol Med Sci. 2005;60:241-7.
17. Silva RC, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal glucose tolerant brazilian adolescents with family history of type 2 diabetes. Diabetes Care. 2005;28:716-8.
18. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care. 2006; 29:2427-32.
19. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512-27.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab. 1979;237:214-23.
21. Geloneze B, Tambascia MA. Avaliação laboratorial e diagnóstico da resistência insulinica. Arq Bras End Metab. 2006;50:208-15.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
23. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, et al. Increased insulin resistance and insulin secretion in nondiabetic african-americans and hispanics compared with non-hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742-8.
24. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in korean non-diabetic adults. J Korean Med Sci. 2006;21:695-700.
25. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The Bruneck Study. Diabetes Care. 2007;30:318-24.
26. Turner RC, Holman RR, Hockaday TDR. Beta cell deficiency in maturity onset diabetes. Lancet. 1976;12:1272-4.
27. Turner R, Holman RR, Matthews D, Hockaday TR, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086-96.
28. Mathews DR, Holman RR, Peto J, Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet. 1982;13:596-8.
29. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95.
30. Levy JC, Matthews DR, Hermans MP, Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191-2.
31. The Oxford Centre for Diabetes, Endocrinology & Metabolism. Diabetes Trial Unit. HOMA Calculator. Disponível em: http://www.dtu.ox.ac.uk/, Acesso em: 20/3/2007.
32. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.
33. Vieira JGH, Avaliação dos potenciais problemas pré-analíticos e metodológicos em dosagens hormonais. Arq Bras Endocrinol Metab. 2002;46:9-15.
34. Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism. 2005;54:206-11.
35. Wallace TM, Levy JC, Matthews DR. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabetic Med. 2004;21:568-76.
36. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362-5.
37. Lansang MC, Williams GH, Carroll S. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens. 2001;14:51-3.
38. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr. 2004;144:47-55.
39. Vaccaro O, Masulli M, Cuomo V, Rivellese AA, Uusitupa M, Vessby B, et al. Comparative evaluation of simple indices of insulin resistance. Metabolism. 2004;53:1522-6.
40. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA. Limitation of the Homeostasis Model Assessment to predict insulin resistance and β-cell dysfunction in older people. J Clin Endocrinol Metab. 2006;91:629-34.
41. Albu JB, Kovera AJ, Allen L, Wainwright M, Berk E, Raja-Khan N, et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in african american than in white nondiabetic women, Am J Clin Nutr. 2005;82:1210-7.
42. Roder ME. Reduced pancreatic β-cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels, J Clin Endocrinol Metab. 2000;85:2275-80.
43. Ryan AS, Nicklas BJ, Berman DM. Aerobic exercise is necessary to improve glucose utilization with moderate weight loss in women. Obesity. 2006;14:1064-72.
44. Donahue RP, Bean JA, Donahue RA, Goldberg RB, Prineas RJ. Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study, Diabetes Care. 1997;20:670-6.
45. Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res. 2002;10:336-44.
46. McAuley K, Mann J. Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance. J Lipid Res. 2006;47:1668-76.
47. McLaughlin TL, Reaven GM, Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. Am J Med. 2003;114:501-2.
48. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M. Homeostatic Model Assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem. 2005;61:381-8.
49. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:500-3.
50. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates o f insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 2000; 23:171-5.
51. Acosta B, Escalona MO, Maiz AG, Pollak FC, Leighton FP. Determinación del índice de resistencia insulínica mediante HOMA en una población de la región metropolitana de Chile. Rev Med Chile. 2002;130:1227-31.
52. Pozzan R, Pozzan R, Brandão AA, Magalhães MEC, Brandão AP. Níveis de insulina e HOMA em uma amostra da cidade do Rio de Janeiro. Estudo do Rio de Janeiro. Rev Socerj. 2003;16:75-5.
53. Ghiringhello MT, Vieira JG, Tachibana TT, Ferrer C, Maciel RMB, Oliveira CHRM, et al. Distribution of HOMA-IR in brazilian subjects with different body mass indexes. Arq Bras Endocrinol Metab. 2006;50:573-4.
54. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643-9.
55. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Cuantificación de insulinoresistencia con los valores de insulina basal e índice HOMA en una población no diabética. Med Clin. 2001;117:530-3.
56. Geloneze B, Repetto EM, Geloneze SR, Tambasela MA, Ermetice MN. The threshold value for insulin resistance (HOMAIR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Prac. 2006;72:219-20.